- Paying the bills -

Ebola: New vaccine trial begins

ebolaTODAY NICARAGUA (Planettechnews.com) In September last year a separate trial of another Ebola vaccine got under way. This latest trial involves 72 volunteers aged 18-50. Initial tests in monkeys showed the vaccine, developed by Janssen Pharmaceutical Companies of Johnson and Johnson, gave complete protection against Ebola.

The volunteers in Oxford are the first humans to receive the vaccine.

Dr Matthew Snape, from the Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics, said: “We aim to immunise all participants within a month. “The main aim is to understand the safety profile of the vaccines.” The trial involves volunteers receiving an additional booster dose one or two months after the initial injection.
Similar small trials will also get under way in the US and three African countries unaffected by Ebola. The first dose is designed to prime the immune system with the second booster dose to enhance the immune response. The two doses contain different components, but both include genes for a protein from the Zaire strain of the Ebola virus. The trial organisers stress the vaccine cannot cause anyone to be infected with Ebola.

Related Articles

Nicaragua breaks with the Vatican

Q24N - Nicaraguan President Daniel Ortega chose to sever diplomatic ties...

assured that the exile of 222 political prisoners was not part of a deal with the US

TODAY NICARAGUA - Nicaraguan dictator, Daniel Ortega, asserted Thursday that he...


- paying the bills -

Let's Keep This Going!

To be updated with all the latest news and information about Nicaragua and Latin America.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.